Microvision, Carl Zeiss Finalize Agreement
BOTHELL, Wash., Sept. 30 -- Microvision Inc. announced that it has signed a multi-year product development and licensing agreement with Carl Zeiss Inc. Under the agreement, the two companies will jointly develop a number of products using Microvision's patented retinal scanning display technology for commercialization in the surgical visualization and ophthalmic diagnostics markets.
Zeiss' Surgical Products Group plans to develop a series of display products incorporating Microvision technology to improve visualization for neurosurgery. The companies also announced that Zeiss would assist in funding ongoing development of a wearable display for neurosurgical navigation under a contract with the Wallace Kettering Neuroscience Center. In addition, Carl Zeiss and Microvision have initiated the development of ophthalmic diagnostic products to be marketed through Zeiss Humphrey Systems.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024